Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Andersson

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Respiratory Medicine|December 7, 2010
Topical nasal steroid treatment does not improve CPAP compliance in unselected patients with OSASWerner Strobel, Manuel Schlageter, Morgan Andersson, et al.
Clinical Physiology and Functional Imaging|December 14, 2011
Inhalation of LPS induces inflammatory airway responses mimicking characteristics of chronic obstructive pulmonary diseaseMagnus Korsgren, Margareta Linden, Neil Entwistle, et al.
NPJ Primary Care Respiratory Medicine|February 5, 2016
TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire studyLars-Olaf Cardell, Petter Olsson, Morgan Andersson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 29, 2002
Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroidCecilia Ahlström-Emanuelsson, Carl G A Persson, Christer Svensson, et al.
Clinical Physiology and Functional Imaging|March 12, 2008
Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPDUlf Nihlén, Peter Montnémery, Morgan Andersson, et al.
Respiratory Research|February 11, 2010
Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitisLennart Greiff, Cecilia Ahlström-Emanuelsson, Ash Bahl, et al.
British Journal of Pharmacology|August 14, 2012
Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donorsAngelica Brandelius, Irma Mahmutovic Persson, Jenny Calvén, et al.
Clinical Physiology and Functional Imaging|June 24, 2005
Challenge-induced plasma exudation and mucinous secretion in human airwaysLennart Greiff, Morgan Andersson, William B Coman, et al.
Journal of Sleep Research|November 7, 2017
Nocturnal nasal obstruction is frequent and reduces sleep quality in patients with obstructive sleep apneaMaria Värendh, Morgan Andersson, Erla Bjørnsdottir, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 8, 2021
HealthSWEDE: costs with sublingual immunotherapy-a Swedish questionnaire studyPetter Olsson, Carl Skröder, Lars Ahlbeck, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Respiratory Medicine|December 7, 2010
Topical nasal steroid treatment does not improve CPAP compliance in unselected patients with OSASWerner Strobel, Manuel Schlageter, Morgan Andersson, et al.
Clinical Physiology and Functional Imaging|December 14, 2011
Inhalation of LPS induces inflammatory airway responses mimicking characteristics of chronic obstructive pulmonary diseaseMagnus Korsgren, Margareta Linden, Neil Entwistle, et al.
NPJ Primary Care Respiratory Medicine|February 5, 2016
TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire studyLars-Olaf Cardell, Petter Olsson, Morgan Andersson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 29, 2002
Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroidCecilia Ahlström-Emanuelsson, Carl G A Persson, Christer Svensson, et al.
Clinical Physiology and Functional Imaging|March 12, 2008
Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPDUlf Nihlén, Peter Montnémery, Morgan Andersson, et al.
Respiratory Research|February 11, 2010
Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitisLennart Greiff, Cecilia Ahlström-Emanuelsson, Ash Bahl, et al.
British Journal of Pharmacology|August 14, 2012
Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donorsAngelica Brandelius, Irma Mahmutovic Persson, Jenny Calvén, et al.
Clinical Physiology and Functional Imaging|June 24, 2005
Challenge-induced plasma exudation and mucinous secretion in human airwaysLennart Greiff, Morgan Andersson, William B Coman, et al.
Journal of Sleep Research|November 7, 2017
Nocturnal nasal obstruction is frequent and reduces sleep quality in patients with obstructive sleep apneaMaria Värendh, Morgan Andersson, Erla Bjørnsdottir, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 8, 2021
HealthSWEDE: costs with sublingual immunotherapy-a Swedish questionnaire studyPetter Olsson, Carl Skröder, Lars Ahlbeck, et al.
Pageof 6